Skye Bioscience, Inc.
SKYE
$3.29
-$0.26-7.32%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -34.45% | -29.04% | 5,344.94% | 1,215.06% | 8,761.90% |
| Total Receivables | -97.54% | -97.35% | -98.11% | -- | -26.60% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.31% | -10.16% | 3.96% | 220.75% | 305.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -93.59% | -67.58% | -76.88% | 17.74% | 29,244.39% |
| Total Current Assets | -41.86% | -33.35% | 507.92% | 422.09% | 4,496.85% |
|
|
|||||
| Total Current Assets | -41.86% | -33.35% | 507.92% | 422.09% | 4,496.85% |
| Net Property, Plant & Equipment | 512.74% | 566.21% | 569.25% | 449.10% | -25.71% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 549.40% | 549.40% | 549.40% | 216.87% | 0.00% |
| Total Assets | -40.22% | -31.68% | 509.39% | 422.52% | 3,802.75% |
|
|
|||||
| Total Accounts Payable | 198.52% | 56.50% | -40.50% | -52.19% | -30.42% |
| Total Accrued Expenses | 37.19% | -60.88% | -14.15% | 108.93% | 33.72% |
| Short-term Debt | -- | -- | -- | -- | 5,263.69% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 146.21% | 149.80% | 153.33% | 20.67% | 20.92% |
| Total Finance Division Other Current Liabilities | -70.16% | -69.03% | -71.76% | -72.13% | -5.79% |
| Total Other Current Liabilities | -70.16% | -69.03% | -71.76% | -72.13% | -5.79% |
| Total Current Liabilities | -41.97% | -66.33% | -68.79% | -59.00% | 45.90% |
|
|
|||||
| Total Current Liabilities | -41.97% | -66.33% | -68.79% | -59.00% | 45.90% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 5,263.69% |
| Capital Leases | 32.79% | 48.01% | 59.58% | -43.25% | -37.73% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -41.30% | -65.25% | -67.23% | -58.79% | 44.16% |
|
|
|||||
| Common Stock & APIC | 6.96% | 6.91% | 94.72% | 93.79% | 182.79% |
| Retained Earnings | -36.12% | -29.84% | -25.45% | -21.25% | -56.37% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -40.01% | -24.89% | 3,296.91% | 4,371.39% | 1,034.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -40.01% | -24.89% | 3,296.91% | 4,371.39% | 1,034.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -40.01% | -24.89% | 3,296.91% | 4,371.39% | 1,034.74% |
|
|
|||||